CY1106136T1 - Συμπιεσμενη συνθεση ταμπλετας που πepιλαμβανει ενα nsaid - Google Patents

Συμπιεσμενη συνθεση ταμπλετας που πepιλαμβανει ενα nsaid

Info

Publication number
CY1106136T1
CY1106136T1 CY20061101083T CY061101083T CY1106136T1 CY 1106136 T1 CY1106136 T1 CY 1106136T1 CY 20061101083 T CY20061101083 T CY 20061101083T CY 061101083 T CY061101083 T CY 061101083T CY 1106136 T1 CY1106136 T1 CY 1106136T1
Authority
CY
Cyprus
Prior art keywords
nsaid
compressed tablet
composition
tablet composition
silicon dioxide
Prior art date
Application number
CY20061101083T
Other languages
Greek (el)
English (en)
Inventor
Robert Arthur Sherry
Tracey Jane Rhoades
Frederick Raymond Higton
Original Assignee
Reckitt Benckiser Healthcare (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929078.5A external-priority patent/GB9929078D0/en
Priority claimed from GBGB9929077.7A external-priority patent/GB9929077D0/en
Application filed by Reckitt Benckiser Healthcare (Uk) Limited filed Critical Reckitt Benckiser Healthcare (Uk) Limited
Publication of CY1106136T1 publication Critical patent/CY1106136T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CY20061101083T 1999-12-09 2006-08-02 Συμπιεσμενη συνθεση ταμπλετας που πepιλαμβανει ενα nsaid CY1106136T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9929078.5A GB9929078D0 (en) 1999-12-09 1999-12-09 Therapeutic agents
GBGB9929077.7A GB9929077D0 (en) 1999-12-09 1999-12-09 Therapeutic agents
PCT/EP2000/012193 WO2001041733A2 (en) 1999-12-09 2000-11-30 Compressed tablet composition comprising a nsaid

Publications (1)

Publication Number Publication Date
CY1106136T1 true CY1106136T1 (el) 2011-06-08

Family

ID=26316111

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101083T CY1106136T1 (el) 1999-12-09 2006-08-02 Συμπιεσμενη συνθεση ταμπλετας που πepιλαμβανει ενα nsaid

Country Status (27)

Country Link
US (1) US8124124B2 (enExample)
EP (1) EP1235558B1 (enExample)
JP (1) JP4040878B2 (enExample)
KR (1) KR20020082464A (enExample)
CN (1) CN100346774C (enExample)
AR (1) AR026917A1 (enExample)
AT (1) ATE324868T1 (enExample)
AU (1) AU776308B2 (enExample)
BG (1) BG66007B1 (enExample)
BR (1) BR0016236A (enExample)
CA (1) CA2393585C (enExample)
CY (1) CY1106136T1 (enExample)
CZ (1) CZ300558B6 (enExample)
DE (1) DE60027761T2 (enExample)
DK (1) DK1235558T3 (enExample)
ES (1) ES2263510T3 (enExample)
HK (1) HK1046644B (enExample)
HU (1) HU227045B1 (enExample)
IL (2) IL150030A0 (enExample)
MX (1) MXPA02005663A (enExample)
NO (1) NO332259B1 (enExample)
NZ (1) NZ519485A (enExample)
PL (1) PL201223B1 (enExample)
PT (1) PT1235558E (enExample)
RU (1) RU2246294C2 (enExample)
SK (1) SK285706B6 (enExample)
WO (1) WO2001041733A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113843D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
CN1688291A (zh) * 2002-02-01 2005-10-26 辉瑞产品公司 含有固体药物分散体的即刻释放剂型
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
US8846088B2 (en) * 2005-02-03 2014-09-30 Takeda Nycomed As Melt granulation of a composition containing a calcium-containing compound
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
JP2009519326A (ja) * 2005-12-16 2009-05-14 ハンミ ファーム． シーオー．， エルティーディー． 低融点の活性成分を含む溶融状の固体分散体、及びこれを含む経口投与用錠剤
ATE489077T1 (de) * 2006-09-28 2010-12-15 Losan Pharma Gmbh Schnell lösliche formulierung von nichtsteroidalen antiphlogistika
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
DE102008048729A1 (de) * 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
US8662705B2 (en) 2010-03-30 2014-03-04 Virwall Systems, Inc. Flexible ultraviolet LED sanitizing apparatus
WO2011135106A1 (es) * 2010-04-26 2011-11-03 Smart Pharma Solutions, S.L Granulado altamente dispersable para la preparación de formulaciones de sustancias activas de altas dosis y procedimiento de obtención del mismo
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)
US20140363508A1 (en) * 2011-12-23 2014-12-11 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
WO2013143688A1 (en) 2012-03-26 2013-10-03 Glatt Ag Taste-masked ibuprofen granules
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
CZ304685B6 (cs) * 2013-12-18 2014-08-27 Technická univerzita v Liberci Způsob rozvádění příze při jejím navíjení na cívku uloženou v navíjecím ústrojí pracovního místa textilního stroje a zařízení k jeho provádění
EP3753921A1 (en) 2014-07-02 2020-12-23 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
US20190022013A1 (en) * 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
BE1023057B1 (nl) * 2016-06-06 2016-11-16 Nordic Specialty Pharma Bvba Ibuprofen tablet
JP6792235B2 (ja) * 2016-09-05 2020-11-25 株式会社アクロエッジ 凝集体の凝集度の測定方法及び凝集度測定装置

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56120616A (en) 1980-02-27 1981-09-22 Kaken Pharmaceut Co Ltd Ibuprofen-containing granule, its preparation, and internal medicine comprising it
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
SE463541B (sv) 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
AU639988B2 (en) 1990-04-11 1993-08-12 Pharmacia & Upjohn Company Taste masking of ibuprofen by fluid bed coating
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
DK138592D0 (da) * 1992-11-17 1992-11-17 Nycomed Dak As Tabletter
AT401871B (de) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
EP0758244B2 (en) * 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9702392D0 (en) * 1997-02-06 1997-03-26 Boots Co Plc Therapeutic agents
GB9710521D0 (en) 1997-05-22 1997-07-16 Boots Co Plc Process
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
IE980115A1 (en) * 1998-02-16 2000-02-09 Biovail Internat Ltd Solubilizing delivery systems and method of manufacture

Also Published As

Publication number Publication date
AU776308B2 (en) 2004-09-02
BG66007B1 (bg) 2010-10-29
MXPA02005663A (es) 2002-09-02
AU3006001A (en) 2001-06-18
CA2393585A1 (en) 2001-06-14
ATE324868T1 (de) 2006-06-15
HUP0203553A2 (hu) 2004-05-28
NZ519485A (en) 2004-02-27
US8124124B2 (en) 2012-02-28
KR20020082464A (ko) 2002-10-31
CZ300558B6 (cs) 2009-06-17
US20030203026A1 (en) 2003-10-30
NO332259B1 (no) 2012-08-13
RU2246294C2 (ru) 2005-02-20
JP2003516341A (ja) 2003-05-13
BG106839A (bg) 2003-03-31
DE60027761D1 (de) 2006-06-08
DE60027761T2 (de) 2007-01-25
JP4040878B2 (ja) 2008-01-30
WO2001041733A2 (en) 2001-06-14
PT1235558E (pt) 2006-09-29
ES2263510T3 (es) 2006-12-16
PL201223B1 (pl) 2009-03-31
CZ20021971A3 (cs) 2002-11-13
CN1433300A (zh) 2003-07-30
NO20022692L (no) 2002-08-07
SK285706B6 (sk) 2007-06-07
AU2004231245A1 (en) 2004-12-23
HK1046644A1 (en) 2003-01-24
HK1046644B (en) 2006-11-10
BR0016236A (pt) 2002-12-24
NO20022692D0 (no) 2002-06-06
EP1235558B1 (en) 2006-05-03
IL150030A0 (en) 2002-12-01
CN100346774C (zh) 2007-11-07
CA2393585C (en) 2007-07-03
DK1235558T3 (da) 2006-10-09
AR026917A1 (es) 2003-03-05
EP1235558A2 (en) 2002-09-04
HU227045B1 (en) 2010-05-28
RU2002118210A (ru) 2004-02-20
PL355491A1 (en) 2004-05-04
SK8022002A3 (en) 2003-07-01
IL150030A (en) 2008-06-05
HUP0203553A3 (en) 2004-06-28
WO2001041733A3 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
CA2393585A1 (en) Therapeutic agents
DK0587744T3 (da) Tygbar sammensætning til frigørelse af et lægemiddel
ES2577389T3 (es) Polímero de ácido láctico y procedimiento para su producción
TR200001810A2 (tr) Hemen Eriyen Oral Dozaj Formülasyonu.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
ES2109377T3 (es) Proceso para la preparacion de una dispersion solida.
HUP0402293A2 (hu) Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására
DE60232496D1 (de) Tabletten, die in der mundhöhle schnell zerfallen
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
JP2003516341A5 (enExample)
DK1256343T3 (da) Flibanserin til behandlingen af extrapyramidale bevægelseslidelser
CY1106542T1 (el) Μεθοδος για παρασκευη φαρμακευτικων συνθεσεων για χρηση με συνταγοποιησεις μαλακης ζελατινης
RU2007126652A (ru) Композиции и способы стабилизации активных фармацевтических ингредиентов
ATE438388T1 (de) Arzneimittel zur gesteuerten freisetzung von paracetamol
KR950031043A (ko) 열 과립화 방법
KR930701963A (ko) 활성성분 방출이 지연되는 용매없는 경구투여 약제 조성물 및 상기 조성물의 제조방법
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
CY1107750T1 (el) Πολυσωματιδιακα σκευασματα ελεγχομενης αποδεσμευσης εκλεκτικου αναστολεα επαναπροσληψης σεροτονινης
AR005353A1 (es) Formulacion de hormona para crecimiento animal de liberacion sostenida, y un procedimiento para la preparacion de la misma
DE60008497D1 (de) Arzneimittel zur oralen verabreichung
NO20010537L (no) Farmasøytiske preparater omfattende ibuprofen og domperidon
ES2036609T3 (es) Granulado exento de aglutinante con lubricacion retardada del producto activo.
DE69813263T2 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
TNSN05203A1 (fr) Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
AR034435A1 (es) Agentes terapeuticos.